Skip to main content
. 2014 Oct 2;4:31. doi: 10.1186/s13613-014-0031-y

Table 3.

Baseline characteristics

Baseline characteristics Study Units Study arms
Significance of results
EPN LPN EN
Age
Bauer 2000 [11]
Years; mean ± SD
53 ± 18
x
55 ± 18
p = ns
Cahill 2011 [12]
64 ± 15.7
62.8 ± 16.3
59.3 ± 16.8
p = 0.095
Casaer 2011 [13]
64 ± 14
64 ± 15
x
p = 0.53
Doig 2013 [14]
68.4 ± 15.1
x
68.6 ± 14.3
NR
Heidegger 2013 [15]
x
61 ± 16
60 ± 16
NR
Kutsogiannis 2011 [16]
62.3 ± 17.9
56.4 ± 17.5
58.4 ± 17.9
p = 0.02^
Gender
Bauer 2000 [11]
Male sex; no (%)
40 (66.7)
x
42 (70)
p = ns
Cahill 2011 [12]
54 (65.1)
54 (68.4)
303 (56)
p = 0.13
Casaer 2011 [13]
1,486 (64.3)
1,486 (63.8)
x
p = 0.75
Doig 2013 [14]
400 (58.7)
x
420 (61.6)
NR
Heidegger 2013 [15]
x
110 (72)
105 (69%)
NR
Kutsogiannis 2011 [16]
121 (64.4)
105 (61.8)
1,563 (61.0)
p = 0.66
BMI
Bauer 2000 [11]
kg/m2; mean ± SD
26 ± 5
x
26 ± 5
p = ns
Cahill 2011 [12]
kg/m2; mean ± SD
26.1 ± 5.3
26.8 ± 5.6
27.4 ± 7.3
p = 0.28
<25 kg/m2; no (%)
41 (49.4)
32 (40.5)
225 (41.6)
p = 0.054*
25 to 30 kg/m2; no (%)
26 (31.3)
25 (31.7)
166 (31.3)
>30 kg/m2; no (%)
16 (19.3)
22 (27.8)
140 (25.9)
Casaer 2011 [13]
<25 kg/m2; no (%)
988 (42.7%)
1,031 (44.2%)
x
p = 0.34
25 to 30 kg/m2; no (%)
852 (36.9)
864 (37.1)
x
>30 kg/m2; no (%)
472 (20.4)
433 (18.6)
x
Doig 2013 [14]
kg/m2; mean ± SD
27.9 ± 6.8
x
28.5 ± 6.9
NR
>30 kg/m2; no (%)
190 (27.9)
x
224 (32.8)
<18.5 kg/m2; no (%)
26 (3.8)
x
20 (2.9)
Heidegger 2013 [15]
kg/m2; mean ± SD
x
25.4 ± 3.9
26.4 ± 4.6
NR
Kutsogiannis 2011 [16]
kg/m2; mean ± SD
24.5 ± 4.7
27.0 ± 6.9
27. 2 ± 7.0
p < 0.0001^
<25 kg/m2; no (%)
120 (63.8)
74 (43.5)
1,143 (44.6)
p < 0.0003^
25 to 30 kg/m2; no (%)
47 (25.0)
53 (31.6)
756 (29.7)
>30 kg/m2; no (%)
21 (11.1)
41 (24.1)
649 (25.3)
Severity of illness
Bauer 2000 [11]
SAPS II score; mean ± SD
43 ± 14
x
41 ± 13
p = ns
Cahill 2011 [12]
APACHE II score; mean ± SD
25.2 ± 8.5
24.9 ± 8.4
24.3 ± 8.5
p = 0.902
Casaer 2011 [13]
APACHE II score; mean ± SD
23 ± 11
23 ± 10
x
p = 0.85
Doig 2013 [14]
APACHE II score; mean ± SD
20.5 (7.4)
x
21.5 (7.8)
NR
Heidegger 2013 [15]
SAPS II score; mean ± SD
x
49 ± 17
47 ± 15
NR
APACHE II score; mean ± SD
x
22 ± 7
23 ± 7
NR
Kutsogiannis 2011 [16]
APACHE II score; mean ± SD
22.6 ± 8.4
23.3 ± 7.9
22.0 ± 7.9
p = 0.11
Amounts of calories delivered
Bauer 2000 [11]
Enteral intake; mean kcal/kg/day on day 7
14.8 ± 4.6
x
13.2 ± 4.3
p = 0.6
Parenteral intake; mean kcal/kg/day on day 7
9.9 ± 3.1
x
1.1 ± 0.3
p < 0.0001
Total intake; mean kcal/kg/day on day 7
24.6 ± 4.9
x
14.2 ± 6.5
p < 0.0001
Cahill 2011 [12]
Enteral intake; mean kcal/kg/day ± SD
5.1 ± 4.9
4.4 ± 3.9
8.8 ± 5.3
p < 0.001
Parenteral intake; mean kcal/kg/day ± SD
12.0 ± 6.3
8.5 ± 5.9
0
p < 0.001
Total intake; mean kcal/kg/day ± SD
17.5 ± 5.8
13.6 ± 6.3
9.9 ± 5.5
p < 0.001
Casaer 2011 [13]
Enteral intake; median kcal/kg/day on day 7, resp day 8
4 vs 4
6 vs 6
x
NR‡
Parenteral intake; median kcal/kg/day on day 7, resp day 8
20 vs 20
3 vs 4
x
Total intake; median kcal/kg/day on day 7
27 vs 26
13 vs 21
x
Doig 2013 [14]
Mean kcal/pt/day on day 1, resp day 7
400 vs 1,300
x
0 vs 1,300
NR
Heidegger 2013 [15]
kcal/kg/day; mean energy delivery between days 4 and 8 ± SD
x
28 ± 5
20 ± 7
p < 0.0001
Kutsogiannis 2011 [16]
Enteral intake; mean kcal/kg/day ± SD
10.2 ± 6.4
7.3 ± 5.1
14.3 ± 6.5
p < 0.001
Parenteral intake; mean kcal/kg/day ± SD
9.0 ± 5.9
7.6 ± 5.9
0
p = 0.02
Total intake; mean kcal/kg/day ± SD
19.5 ± 6.2
15.7 ± 6.1
15.2 ± 6.5
p < 0.001
Amounts of proteins delivered
Bauer 2000 [11]
 
NR
x
NR
 
Cahill 2011 [12]
Adequacy of protein (%); mean ± SD
71.5 ± 24.9
53.2 ± 22.7
38.7 ± 21.6
p < 0.001
Casaer 2011 [13]
 
NR
NR
x
 
Doig 2013 [14]
 
NR
x
NR
 
Heidegger 2013 [15]
g/kg/day; mean protein delivery between day 4 and 8 ± SD
x
1.2 ± 0.2
0.8 ± 0.3
p < 0.0001
Kutsogiannis 2011 [16]
Enteral intake; mean g/kg/day ± SD
0.53 ± 0.33
0.47 ± 0.29
0.77 ± 0.35
p < 0.0001
Parenteral intake; mean g/kg/day ± SD
0.63 ± 0.39
0.71 ± 0.40
0
p = 0.48
Total intake; mean g/kg/day ± SD
0.94 ± 0.40
0.77 ± 0.30
0.77 ± 0.35
p < 0.0001
Type of nutrition Bauer 2000 [11]
EN: modular polymeric diet: protein (20%), polyunsaturated fats (30%), carbohydrates (50%), nonsoluble fibers, sodium chloride (2 g/l), potassium chloride (3 g/l) and a standard solution of hydro- and liposoluble vitamins
PN: 3-in-1 solution of carbohydrates, fat and protein, Vitrimix KV and hydrosoluble vitamins, Soluvit
Placebo: sodium chloride 0.9% with intralipid 20% (50 ml/l) and Soluvit (10 ml/l)
Cahill 2011 [12]
NR
Casaer 2011 [13]
EN: mainly Osmolite
EPN: intravenous 20% glucose solution on days 1 and 2. On day 3: PN was initiated
LPN: intravenous 5% glucose solution. On day 8: PN was initiated
PN: trace elements, minerals (potassium, phosphate, magnesium) and vitamins
Doig 2013 [14]
Standard care: was defined pragmatically and not via protocol. The attending clinician selected the route, starting rate, metabolic targets and composition of nutrition.
PN: standard parenteral nutrition from a ready-to-mix three-chamber bag containing amino acids, glucose, lipids, and electrolytes (Kabiven G19%). Trace elements, minerals and vitamins were added as clinically appropriate.
Heidegger 2013 [15]
EN: polymeric, fibre-enriched formulas, containing 1.05 to 1.62 kcal/ml of energy (18% proteins, 29% lipids (8% medium-chain triglycerides), 53% carbohydrates)
PN: 0.62 to 1.37 kcal/ml of energy (20% proteins, 29% lipids (15% medium-chain triglycerides), 51% carbohydrates).
Kutsogiannis 2011 [16] NR

EPN, early parenteral nutrition; LPN, late parenteral nutrition; EN, enteral nutrition; SD, standard deviation; x, not applicable; p, p-value; ns, nonsignificant; NR, not reported; no, number of patients; %, percentage; kg/m2, weight in kilograms divided by height in meters squared; SAPS II score, simplified acute physiology score; APACHE II score, score on the Acute Physiology and Chronic Health Evaluation II (range from 0 to 71, with higher scores indicating a greater severity of illness); kcal, kilocalories; kg, kilograms; resp, respectively; vs, versus; g, grams; PN, parenteral nutrition; l, liters.

NB: studies use different definitions for EPN, LPN and EN. ^, comparing EPN versus EN and EPN versus LPN; *, in this EN group information of 10 patients is missing; , comparing EPN versus EN and LPN versus EN; , these are estimated values from a figure, as no values are given.